BETRFOTCPharmaceutical PreparationsFiscal year ends January 31
BetterLife Pharma Inc.
Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)
Close on Oct 19, 2026
- Market cap
- $22.36M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
BetterLife Pharma has not reported a dividend
No dividend per share appears in BetterLife Pharma's annual filings since fiscal 2011.